← Evidence map

ArticleMedicina (Kaunas, Lithuania)2026

The Short-Term Outcomes of Intravitreal Faricimab for Treatment-Naïve and -Refractory Neovascular Age-Related Macular Degeneration: A Real-World Study.

Huai-Lung Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The Short-Term Outcomes of Intravitreal Faricimab for Treatment-Naïve and -Refractory Neovascular Age-Related Macular Degeneration: A Real-World Study. | OpenQuestion